129 related articles for article (PubMed ID: 10077451)
21. Feedback inhibition of polyisoprenyl pyrophosphate synthesis from mevalonate in vitro. Implications for protein prenylation.
Lutz RJ; McLain TM; Sinensky M
J Biol Chem; 1992 Apr; 267(12):7983-6. PubMed ID: 1569056
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
[TBL] [Abstract][Full Text] [Related]
23. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
25. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts.
Vogt A; Qian Y; McGuire TF; Hamilton AD; Sebti SM
Oncogene; 1996 Nov; 13(9):1991-9. PubMed ID: 8934546
[TBL] [Abstract][Full Text] [Related]
26. Cerivastatin-induced apoptosis of human aortic smooth muscle cells through partial inhibition of basal activation of extracellular signal-regulated kinases.
Takata R; Fukasawa S; Hara T; Nakajima H; Yamashina A; Yanase N; Mizuguchi J
Cardiovasc Pathol; 2004; 13(1):41-8. PubMed ID: 14761784
[TBL] [Abstract][Full Text] [Related]
27. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K
J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486
[TBL] [Abstract][Full Text] [Related]
28. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of (S)-isoprenoid thiodiphosphates as substrates and inhibitors.
Phan RM; Poulter CD
J Org Chem; 2001 Oct; 66(20):6705-10. PubMed ID: 11578224
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation.
Alp Yildirim Fİ; Kaleli Durman D; Aypar E; Ark M; Özdemir O; Uydeş Doğan BS
Fundam Clin Pharmacol; 2016 Apr; 30(2):96-106. PubMed ID: 26610064
[TBL] [Abstract][Full Text] [Related]
31. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
32. Newly synthesized Rho A, not Ras, is isoprenylated and translocated to membranes coincident with progression of the G1 to S phase of growth-stimulated rat FRTL-5 cells.
Noguchi Y; Nakamura S; Yasuda T; Kitagawa M; Kohn LD; Saito Y; Hirai A
J Biol Chem; 1998 Feb; 273(6):3649-53. PubMed ID: 9452494
[TBL] [Abstract][Full Text] [Related]
33. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.
Sindermann JR; Fan L; Weigel KA; Troyer D; Müller JG; Schmidt A; March KL; Breithardt G
Atherosclerosis; 2000 Jun; 150(2):331-41. PubMed ID: 10856525
[TBL] [Abstract][Full Text] [Related]
34. Isoprenoids influence expression of Ras and Ras-related proteins.
Holstein SA; Wohlford-Lenane CL; Hohl RJ
Biochemistry; 2002 Nov; 41(46):13698-704. PubMed ID: 12427032
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity.
Xiao H; Qin X; Ping D; Zuo K
PLoS One; 2013; 8(3):e59233. PubMed ID: 23555637
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
[TBL] [Abstract][Full Text] [Related]
37. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
Duncan RE; Lau D; El-Sohemy A; Archer MC
Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
[TBL] [Abstract][Full Text] [Related]
38. Quantitative determination of isopentenyl diphosphate in cultured mammalian cells.
Tong H; Kuder CH; Wasko BM; Hohl RJ
Anal Biochem; 2013 Feb; 433(1):36-42. PubMed ID: 23000003
[TBL] [Abstract][Full Text] [Related]
39. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
